What are the treatment options for symptomatic uterine fibroids in a woman who wishes to preserve fertility?

Treatment Options for Symptomatic Uterine Fibroids with Fertility Preservation

For women desiring future fertility with symptomatic uterine fibroids, myomectomy (hysteroscopic for submucosal fibroids <5cm, laparoscopic or open for intramural/subserosal fibroids) is the definitive surgical treatment, while medical management with GnRH antagonists plus add-back therapy serves as first-line therapy or preoperative preparation. 1, 2

Medical Management Algorithm

First-Line Medical Therapy

• Start with combined oral contraceptive pills or levonorgestrel IUD for mild-to-moderate bleeding symptoms, as these reduce menstrual blood loss without compromising future fertility 1

• Add tranexamic acid (1-1.5g every 6-8 hours during bleeding episodes) as a nonhormonal adjunct if breakthrough bleeding persists or if hormonal therapy is contraindicated 1, 2

• NSAIDs for 5-7 days during bleeding episodes provide modest reduction in menstrual blood loss and pain control 1, 3

Second-Line Medical Therapy

• Initiate oral GnRH antagonists (relugolix, elagolix, or linzagolix) with mandatory low-dose estrogen/progestin add-back therapy when first-line options fail, as these agents reduce both bleeding symptoms and fibroid volume by 18-30% 1, 2, 3

• GnRH antagonists with add-back therapy can be used for up to 24 months without clinically meaningful bone loss, but fertility is suppressed during treatment and symptoms recur rapidly after cessation 1, 2, 3

• Use GnRH therapy for 3-6 months preoperatively to shrink fibroids, correct anemia, and facilitate surgical resection if myomectomy is planned 1, 2

• Never use GnRH agonists or antagonists as monotherapy beyond 3-6 months without add-back therapy due to severe hypoestrogenic effects including headaches, hot flashes, hypertension, and significant bone mineral density loss 1, 2, 3

Surgical Management Based on Fibroid Location

Submucosal Fibroids (<5cm)

• Hysteroscopic myomectomy is the procedure of choice for pedunculated or sessile submucosal fibroids, achieving pregnancy rates of 85% and live birth rates of 65% 1, 2

• This approach provides shorter hospitalization and faster return to activities compared to laparoscopic or open myomectomy, with equivalent quality of life improvement at 2-3 months 1

• Risks include uterine perforation, fluid overload, blood transfusion, bowel/bladder injury, and need for reintervention 1

Intramural and Subserosal Fibroids

• Laparoscopic myomectomy is preferred for single or few fibroids with shorter hospital stays and faster recovery compared to open myomectomy 1, 2

• Open myomectomy is indicated for multiple fibroids or very large uteri where laparoscopic approach is technically challenging 1

• Both approaches provide improved quality of life for up to 10 years, though less than half of patients attempting conception achieve pregnancy, and of these, less than half result in live births 1, 2

• Robotic-assisted laparoscopic myomectomy shows similar outcomes to traditional laparoscopy in operative time, hospital stay, and complications 1

Alternative Fertility-Preserving Interventions

Laparoscopic Uterine Artery Occlusion (LUAO)

• LUAO demonstrates comparable pregnancy rates to UAE (67% vs 69%), live births (46% vs 50%), and abortion rates (33% vs 34%) 1

• LUAO shows lower postprocedural complications and rehospitalizations compared to UAE, though UAE achieves greater fibroid diameter reduction (53% vs 39%) and complete infarction (82% vs 23%) 1

Uterine Artery Embolization (UAE)

• UAE is controversial for women actively seeking pregnancy due to insufficient evidence, though total pregnancy rates of 69%, live births of 50%, and abortion rates of 34% have been reported 1, 2

• UAE provides immediate symptom control in 73-98% of patients with sustained relief in 72-73% at 5 years, but reintervention rates reach 28% by 5 years and 35% by 10 years 4, 2, 5

• In a randomized trial, myomectomy showed improved quality of life scores at 2 years compared to UAE, though this difference was no longer significant at 4 years 1

MR-Guided Focused Ultrasound (MRgFUS)

• MRgFUS has limited fertility data with registry reports showing 54 pregnancies in 51 women, 41% live births, 28% spontaneous abortions, and 43% pregnancy-related complications 2

• MRgFUS demonstrates higher reintervention rates (30%) compared to UAE (13%) and decreased symptom control, making it less favorable for fertility preservation 1, 2

Critical Decision Points and Pitfalls

When to Avoid Intervention

• Do not treat asymptomatic fibroids in women attempting conception, as interventions carry operative risks including uterine perforation, blood transfusion, and potential adverse pregnancy outcomes 2

• Intramural fibroids without cavity distortion do not impair fertility (implantation rates 16% vs 16% in controls) and should not be removed, as surgery adds risk without benefit 2

When Myomectomy is Mandatory

• Remove submucosal or cavity-distorting intramural fibroids before conception attempts, as cavity distortion reduces implantation rates to 6% (vs 16% without distortion) and pregnancy rates to 10-16% (vs 30% in controls) 2, 6

• Perform myomectomy via anterior uterine incision for intramural fibroids with cavity distortion to optimize fertility outcomes 2

Anemia Management

• Start iron supplementation immediately while initiating medical therapy to correct anemia from chronic bleeding 3

• Consider preoperative GnRH therapy for 3 months to reduce fibroid size and correct anemia before surgery 2, 3

Counseling Requirements

• Counsel all patients that pregnancy is possible after any fertility-preserving procedure including hysteroscopic myomectomy, laparoscopic/open myomectomy, and LUAO, even if they state no current desire for fertility 1

• Inform patients that GnRH antagonist therapy suppresses fertility during treatment and symptoms recur rapidly after discontinuation 1, 2, 3

• Advise that myomectomy provides superior reproductive outcomes to UAE with higher clinical pregnancy and live birth rates, and lower spontaneous abortion, abnormal placentation, preterm labor, and malpresentation rates 6

Treatment Failure and Escalation

• If medical management with GnRH antagonists plus add-back therapy fails after 3-6 months, proceed to surgical intervention based on fibroid location and patient reproductive goals 2, 3

• If symptoms persist after myomectomy, consider that concomitant adenomyosis may be present, which is less responsive to fibroid-directed therapy 1

• Hysterectomy should be avoided unless less invasive procedures cannot provide adequate symptom relief, as it is associated with higher complication rates, longer hospitalization, and long-term risks including cardiovascular disease, osteoporosis, and dementia 1, 4, 2